Influenza News and Research

Latest Influenza News and Research

Study describes radiologic findings in H7N9 pneumonia

H7N9 pneumonia is characterized by imaging findings that differentiate it from other types of pneumonia, including rapidly progressive changes in the lungs and pulmonary connective tissues, according to the first study to describe radiologic findings in the disease. The results are published online in the journal Radiology.

2 Jul 2013

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides, Inc. announced today that it has submitted its letter of intent to file an Orphan Drug Application with the European Medicines Agency for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

1 Jul 2013

Two symposia focusing on infectious diseases to be held in Minnesota

Two symposia focusing on the ecological dynamics of infectious diseases such as avian influenza, Yellow Fever, and Lyme will take place during the Ecological Society of America's 98th Annual Meeting, held this year in Minneapolis, Minnesota.

29 Jun 2013

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.

28 Jun 2013

Research shows influenza infection increases susceptibility to pneumococcus bacteria by 100-fold

It's been known for more than two centuries that pneumonia cases increase during flu epidemics. But population-level epidemiological studies looking at seasonal patterns of influenza and pneumococcal pneumonia incidence have revealed either a modest association or have failed to identify any signature of interaction between the two.

27 Jun 2013

Research: Flu shot effective in preventing flu, even if virus does not match vaccine

New research out of St. Michael's Hospital has found that despite popular belief, the flu shot is effective in preventing the flu, even if the virus going around does not match the vaccine.

26 Jun 2013

UW receives $10 million to develop paper-based pathogen identification test

The University of Washington has received nearly $10 million from the U.S. Department of Defense to continue a project aimed at building a small, paper-based device that could test for infectious diseases on-demand in areas where diagnostic capabilities are limited.

26 Jun 2013

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

Patients are not at increased risk of Guillain-Barr- syndrome in the six-week period after vaccination with any vaccine, including influenza, according to a Kaiser Permanente study published in Clinical Infectious Diseases.

25 Jun 2013

Medicago produces Rotavirus VLP vaccine candidate using plant-based manufacturing platform

Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.

20 Jun 2013

Anthem revises medical and pharmacy guidelines to help members recover from Colorado wildfires

Anthem Blue Cross and Blue Shield in Colorado announced this morning that it has revised medical and pharmacy guidelines and extended support services to help members in El Paso, Fremont and Huerfano counties who are directly impacted by the Black Forest, Royal Gorge, Klikus or La Veta wildfires.

15 Jun 2013

Experts raise awareness about the importance of flu vaccine

The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person's risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.

14 Jun 2013

Value of vaccinating children, young adults for influenza underestimated, experts say

The huge value of vaccinating more children and young adults for influenza is being seriously underestimated, experts say in a new report, while conventional wisdom and historic vaccine programs have concentrated on the elderly and those at higher risk of death and serious complications.

13 Jun 2013

Glycoproteins in saliva of older people are more efficient in binding to influenza

Spit. Drool. Dribble. Saliva is not normally a topic of polite conversation, but it may be the key to explaining the age and sex bias exhibited by influenza and other diseases, according to a new study.

13 Jun 2013

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.

11 Jun 2013

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

11 Jun 2013

Mandatory influenza vaccination does not lead to excessive voluntary termination

Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.

10 Jun 2013

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

10 Jun 2013

New comprehensive effort to model how humans respond to viral pathogens

In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these viral pathogens.

7 Jun 2013

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").

6 Jun 2013

Study: Offering flu vaccines at elementary schools could expand vaccination rates, reduce costs

Offering flu vaccines at elementary schools could expand vaccination rates and reduce costs, according to a new study reported in the scientific journal Vaccine by researchers from UC Davis Health System; the Monroe County, New York, Department of Public Health; University of Rochester Medical Center; and U.S. Centers for Disease Control and Prevention.

6 Jun 2013

Influenza News and Research

Latest Influenza News and Research

Study describes radiologic findings in H7N9 pneumonia

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

Two symposia focusing on infectious diseases to be held in Minnesota

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Research shows influenza infection increases susceptibility to pneumococcus bacteria by 100-fold

Research: Flu shot effective in preventing flu, even if virus does not match vaccine

UW receives $10 million to develop paper-based pathogen identification test

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

Medicago produces Rotavirus VLP vaccine candidate using plant-based manufacturing platform

Anthem revises medical and pharmacy guidelines to help members recover from Colorado wildfires

Experts raise awareness about the importance of flu vaccine

Value of vaccinating children, young adults for influenza underestimated, experts say

Glycoproteins in saliva of older people are more efficient in binding to influenza

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Mandatory influenza vaccination does not lead to excessive voluntary termination

NanoViricides files Orphan Drug application with FDA for DengueCide

New comprehensive effort to model how humans respond to viral pathogens

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

Study: Offering flu vaccines at elementary schools could expand vaccination rates, reduce costs

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Influenza News and Research

Latest Influenza News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in